
You are here
Consultations
We conduct public consultations as part of our broader stakeholder engagement work, including on changes to regulatory requirements or practices, reviews of business processes, standards or guidelines, and TGA fees and charges.
Filters
Status
Categories
- Advertising (2) Apply Advertising filter
- Australian Register of Therapeutic Goods (ARTG) (1) Apply Australian Register of Therapeutic Goods (ARTG) filter
- Biologicals (2) Apply Biologicals filter
- Remove Blood and blood components filter Blood and blood components (0)
- Complementary medicines (7) Apply Complementary medicines filter
- Fees/Payments (1) Apply Fees/Payments filter
- Import/Export (1) Apply Import/Export filter
- Labelling/Packaging (1) Apply Labelling/Packaging filter
- Legislation (3) Apply Legislation filter
- Remove Listed medicines filter Listed medicines (2)
- Medical devices/IVDs (55) Apply Medical devices/IVDs filter
- Medical devices safety (1) Apply Medical devices safety filter
- Remove Medicines filter Medicines (2)
- Medicines safety (1) Apply Medicines safety filter
- OTC medicines (12) Apply OTC medicines filter
- Other therapeutic goods (1) Apply Other therapeutic goods filter
- Remove Prescription medicines filter Prescription medicines (5)
- Remove Safety of medicines & medical devices filter Safety of medicines & medical devices (0)
- Scheduling (55) Apply Scheduling filter
- Remove Therapeutic Goods Administration (TGA) filter Therapeutic Goods Administration (TGA) (2)
- Therapeutic goods regulation (2) Apply Therapeutic goods regulation filter
- (-) Remove Medicines filter Medicines
- (-) Remove Safety of medicines & medical devices filter Safety of medicines & medical devices
- (-) Remove Listed medicines filter Listed medicines
- (-) Remove Therapeutic Goods Administration (TGA) filter Therapeutic Goods Administration (TGA)
- (-) Remove Blood and blood components filter Blood and blood components
- (-) Remove Prescription medicines filter Prescription medicines
Repurposing of medicines
Closed on 1 April 2022
Adoption of International Scientific Guidelines in Australia
Closed on 20 February 2022
Consultation on Extemporaneous Compounding of Emergency Medicines
Closed on 7 February 2022
Proposed changes to the Permissible Ingredients Determination: Low-negligible risk changes 2021-22
Closed on 15 September 2021
Building a more robust medicine supply - proposals to help prevent, mitigate and manage medicine shortages
Closed on 17 May 2021
Repurposing of prescription medicines
Closed on 30 March 2021
Fees and charges proposal 2021-22
Closed on 17 March 2021
Proposal to remove redundant processes for entering certain formulation information into a therapeutic goods application
Closed on 24 February 2021
Changes to permissible ingredients - Low-negligible risk
Closed on 11 October 2019